Hormone Cell Interaction Flashcards

1
Q

Endocrine hormones

A

. Released by glands into circulation

. Affects distant target cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Neurohormones

A

. Secreted by neurons into circulation

. Influences distant target cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Paracrine

A

. Secreted by cells into ECF affecting neighboring cells of different type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cytokines

A

. Peptides secreted by cells into ECF that function as autocrines, paracrines or endocrine hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classes of hormones

A

. Peptides/proteins
. Steroids
. AA derivatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Peptides/proteins hormone class

A

. Synthesized as prohormone or pre-pro-hormone
. Stored in membrane bound secretory vesicles in cytoplasm
. Released by Ca-dependent exocytosis
. Circulate in blood as unbound form: have short half-life times
. Do not cross cell membranes
. Interact w/ membrane receptors
. Second messengers required for signal transduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Steroid hormone class

A

. Lipid soluble
. Readily released as they are synthesized
. Not stored
. Require plasmatic protein transporters
. Interact w/ intracellular receptors to influence protein synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Amino acid derivative hormone class

A

. Thyroid hormones: stored in follicle as part of thyroglobulin, cross cell membranes, transported in blood bound to proteins, have intracellular receptors
. Catecholamines: stored in membrane-bound vesicles, don’t cross membranes, transported in blood free or loosely assoc. w/ proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Competitive antagonist effect on potency and efficacy

A

. Antagonist dec. potency but does not change efficacy

. Degree of shift depends on affinity and receptor coupling of competing chemical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Magnitude of biological responses mainly depends on ____

A

Number of hormone-receptor complexes
. Formation of complexes is non-covalent and follows 1st order molecular kinetics
. Affinity constant = [HR]/[H] x [R]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Is the hormone considered in [H] free or bound to protein?

A

free

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hormone secretion

A

. Most hormones released in short pulsatile bursts
. To inc. secretion the bursts happen more frequently
. Frequency of bursts and oscillations of frequency depends on external factors (light-dark, sleep-wake)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Metabolic clearance

A

. Catabolic clearance rate (MCR) of hormone represents the volume of plasma cleared of hormone per unit time
. Occurs primarily via removal and metabolism in liver and kidneys
. Some hormones removed or metabolized after uptake by target cell
. Half-life of hormone is inversely related

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hormone half life

A

. Ranges from 2-3 minutes to 6/5 days
. Polypeptide and protein hormones that freely dissolve in plasma H2O generally have a shorter half-life than steroid hormones that are largely bound to transport proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Affinity in hormones

A

Receptors must have high affinity bc free hormone is in low concentrations

Affinity = [HR]/[H] x [R]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Equilibrium dissociation

A

. Concentration of hormone at specified equilibrium conditions that is required for binding to 50% of the receptor sites
. Lower the Kd concentration, the higher the affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Concentration of receptors

A

. Receptor concentration can be unregulated or downregulated
. They are continuously synthesized and degraded
. Modulation by primary hormone is homologous regulation (low conc. Of primary hormone inc. receptor conc.)
. Modulation by non-primary hormone is heterologous (different hormone inc. another hormone’s receptors in target cell)
. Biological response of target cell is directly proportional to number of occupied receptor sites

18
Q

Exception condition when Kd and ED50 are not equivalent

A

. When the max biological response of target cell occurs despite all receptor sites NOT bring occupies
. Kd is then lower than the ED50

19
Q

T/F endocrine feedback loops are proportional

A

T

. Rate of secretion varies btw 0 and maximal rather than on or off

20
Q

Essential component of feedback loop

A

. Stimulus
. Sensor
. Setpoint: required conc. Of hormone
. Integrating center: comparison of actual and required conc. Of controlled variable occurs (and where error signal develops)
. Effector: mechanism that returns level of controlled variable toward desired setpoint

21
Q

Positive feedback loop

A

. Non-regulatory and unstable
. Deviation from setpoint will be inc. by effector
. Example: parturition: oxytocin stimulates and enhances labor contractions, as baby moves down pressure receptors w/in cervix send signals to produce more oxytocin
. When stimulus to receptor ends, the hormone production stops

22
Q

Permissiveness

A

. Hormone A must be present for full expression of hormone B’s effect

23
Q

Counter regulatory hormones

A

. Different hormones have opposing effects on the same variable

24
Q

Trophic

A

. Hormones stimulate the secretion of another hormone and usually the growth of that endocrine gland

25
Q

Syngery

A

. Occurs when 2 hormones produce the Sam biological response
. Simultaneously produce a response that is greater than the sum of the individual responses to each hormone

26
Q

Protein hormones are secreted by ____

A

Ca-dependent exocytosis

. Secretory vesicles fuse w/ plasma membrane, vesicle opens releasing contents into extracellular space

27
Q

Peptide hormone transport

A

. Hydrophilic and soluble in plasma

. Do not require transport proteins except somatomedins (IGF)

28
Q

Peptide metabolism

A

. Remain in bloodstream only for a short time after secretion
. Receptor-mediated degradation is 1 pathway for metabolism of some peptide hormones
. For most peptide/protein hormones, kidney and liver are major sites of hormonal degradation
. Polypeptides and lower molecular weight protein hormones are more readily filtered by kidney and excreted
. Polypeptide hormones have a shorter half-life (min) than larger protein hormones (hours)

29
Q

Classes of steroids

A

. Estrogens
. Androgens (testosterone)
. Glucocorticoids (cortisol)
. Mineralcorticoids (aldosterone)

30
Q

Steroids are produced in what locations?

A

. Adrenal cortex
. Testes
. Ovary
. Placenta

31
Q

Steroid synthesis

A

. LDL Major source of cholesterol
. Binding of LDL to membrane receptor causes internalization of LDL-receptor complex via endocytosis
. Cholesterol is then stored in esterified form
. Upon ACTH or LTH stimulation, free cholesterol is released from lipid droplet by cholesterol esterase (activated by PKA)
. Free cholesterol transported to mitochondria by steroidogenic acute regulatory (StAR) protein and internalized by peripheral-type benzo receptor (PBR)
. Cholesterol modified by cytochrome P450s and other enzymes to produce pregnolone (common steroid precursor)

32
Q

Rate limiting step in all steroid synthesis

A

. Conversion of cholesterol to pregnenolone in mitochondria

33
Q

Rate of steroid secretion is controlled by the rate of ____

A

Steroid synthesis

34
Q

Transport of steroids in plasma

A

. Lipophilic (little dissolved in plasma, most bound to transport proteins)
. Hormone bound to protein in equilibrium w/ free hormone in plasma
. Dissociation of hormone from carrier protein is slow process and hormone remains attached to specific carrier as blood transverse capillary beds
. Dissociation of hormone from non-specific protein carriers does occur in capillary beds
. Binding and unwinding keeps free hormone conc. Constant

35
Q

T/F in presence of intact regulatory systems, alterations in hormone-binding proteins do not chronically alter endocrine status bc the free conc. Of hormone is adjusted back to setpoint

A

T

36
Q

Steroid mechanism of action

A

. Receptor in cell nucleus (can be in cytoplasm)
. Binding of hormone to receptor activated DNA-binding domain
. Hormone receptor complex binds to specific sequences of DNA to modify transcription
. Biological effect takes longer compared to response via second messenger production

37
Q

Steroid metabolism

A

. Have long half-life
. Metabolized in series of reduction reactions that primarily take place in liver
. Metabolites conjugated w/ sulfates or glucouronides and secreted into bile or plasma. For excretion via GI or kidneys

38
Q

Enzymes that control formation of eicosanoids

A

. Thromboxane
. Prostacyclines
. Prostaglandins
. Leukotrienes

39
Q

Prostaglandins

A

. Generated from COX enzyme
. Modulate many biological activities
. Type synthesized in a particular tissue is determined by specific complement of enzymes w/in cell
. Interact w/ receptors on local target cells in paracrine or autocrine fashion
. Very short half-life (minutes)

40
Q

Leukotrienes

A

. Generated from arachidonic acid via 5-lipoxygenase
. Classified as LTB4, LTC4, LTD4, LTE4, and LTF4
. Interact w/ receptors on local target cells in paracrine or autocrine way
. LTB4 is important in inflammatory response
. LTC4, D4, and E4 are potent constrictors of smooth mm. In trachea, lung, and arterioles
. Stimulate mucous secretion
. Play role in asthma, gout, IBD, RA, psoriasis, adult respiratory distresss yndrome, and allergies

41
Q

Thromboxanes

A

. Role in hemostasis
. thromboxane A2 is most important
. Platelets convert PGH2 into TA2 which aggregates platelets, induce platelet aggregation, and induce vasoconstriction

42
Q

Prostacyclins

A

. Endothelial cells can convert PGH2 to prostacyclin I2 (PGI2) which inhibits platelet aggregation and dilates blood vessels